Tag Archives: Humira

Shire Takeover "Could Save AbbVie $8 Billion Tax on Humira over Next 15 Years"

AbbVie’s recent $54 billion acquisition of Shire and subsequent relocation to Ireland will mean substantial tax savings for the US pharmaceutical giant, according to analysts at research and consulting firm GlobalData.
Posted in Deals, Europe, Global, Strategy | Also tagged , , , | Leave a comment

Pharm Exec's Brands of Yesteryear: Where Are They Now?

Pharm Exec’s Brand of the Year selections from the last few years are still alive and kicking, although some have aged more gracefully than others. The US drug pricing wars may be coming, but these products already made their mint. We checked back in with them to see how things are going, and to look […]
Posted in Pharm Exec Magazine, R&D, Strategy | Also tagged , , , , , | Leave a comment

FDA Strengthens Warnings on TNF Inhibitors

On Tuesday, FDA announced that makers of tumor necrosis factor (TNF) blockers must change their labels to include boxed warnings for “increased risk of lymphoma and other malignancies in children and adolescents.” That’s in addition to the current box warning that the drugs might lead to cancer. TNF blockers (or inhibitors) are used to reduce […]
Posted in News | Also tagged , , , , , | 1 Comment
  • Categories

  • Meta